Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts
- PMID: 214228
Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts
Abstract
Cultures of Rous sarcoma virus-transformed chick embryo fibroblasts (RSVCEF) produce 50-fold more of the protease plasminogen activator (PA), than do normal chick embryo fibroblasts. Treatment of RSVCEF cultures with the tumor promoter phorbol myristate acetate (PMA) further enhances (8- to 12-fold) the level of PA activity. Increased levels of PA activity in RSVCEF are observed as early as 1 to 2 hr after PMA treatment. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrates that the PA produced by PMA-treated cultures has a molecular weight identical to that of the PA produced by untreated cultures. PA induction by PMA cannot be accomplished in cell-free extracts, but requires protein synthesis in intact cells. Under serum-free conditions, PMA-treated RSVCEF secrete high levels of PA for 4 to 6 days and undergo pronounced morphological alterations. Modified culture conditions and the use of PMA to induce PA has allowed for the accumulation of large amounts of RSVCEF culture fluid and the subsequent purification of the enzyme. The sensitivity of transformed CEF to PMA and the generation of enhanced proteolytic activity in the cellular microenvironment may provide a model system to examine the role of both PA in malignant transformation and PMA in tumor promotion.
Similar articles
-
Modulation of plasminogen activator synthesis in chick embryo fibroblasts by cyclic nucleotides and phorobol myristate acetate.Cancer Res. 1979 May;39(5):1579-86. Cancer Res. 1979. PMID: 218731
-
Plasminogen activator and the membrane of transformed cells.Prog Clin Biol Res. 1980;41:773-96. Prog Clin Biol Res. 1980. PMID: 6256777
-
Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator.Cell. 1979 May;17(1):131-41. doi: 10.1016/0092-8674(79)90301-5. Cell. 1979. PMID: 222474
-
Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes.J Supramol Struct. 1979;12(2):195-208. doi: 10.1002/jss.400120206. J Supramol Struct. 1979. PMID: 397370 Review.
-
Microenvironmental regulation of the initiated cell.Adv Cancer Res. 2003;90:1-62. doi: 10.1016/s0065-230x(03)90001-7. Adv Cancer Res. 2003. PMID: 14710946 Review.
Cited by
-
The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.Cancer Metastasis Rev. 1990 Dec;9(4):353-67. doi: 10.1007/BF00049524. Cancer Metastasis Rev. 1990. PMID: 2129023 Review.
-
Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.J Exp Med. 1984 Mar 1;159(3):935-51. doi: 10.1084/jem.159.3.935. J Exp Med. 1984. PMID: 6199454 Free PMC article.
-
12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts.Proc Natl Acad Sci U S A. 1982 Dec;79(24):7886-90. doi: 10.1073/pnas.79.24.7886. Proc Natl Acad Sci U S A. 1982. PMID: 6961458 Free PMC article.
-
The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants.J Cell Biol. 1985 Nov;101(5 Pt 1):1790-8. doi: 10.1083/jcb.101.5.1790. J Cell Biol. 1985. PMID: 2997235 Free PMC article.
-
Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.J Exp Med. 1983 Jan 1;157(1):259-72. doi: 10.1084/jem.157.1.259. J Exp Med. 1983. PMID: 6681540 Free PMC article.